tiprankstipranks
Doseology Sciences, Inc. (DE:VU70)
FRANKFURT:VU70
Germany Market
VU70
Doseology Sciences
RESEARCH TOOLSreports

Doseology Sciences (VU70) Ratios

0 Followers

Doseology Sciences Ratios

DE:VU70's free cash flow for Q4 2025 was C$0.35. For the 2025 fiscal year, DE:VU70's free cash flow was decreased by C$ and operating cash flow was C$-219.61. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
 10.31 15.85 13.36 14.66 13.58
Quick Ratio
 8.48 15.67 13.36 14.57 13.53
Cash Ratio
 4.54 15.19 12.85 14.21 8.56
Solvency Ratio
 -14.45 -4.76 -3.87 -17.29 -2.07
Operating Cash Flow Ratio
 -1.26 -3.64 -2.85 -5.25 -7.82
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 -11.27 -18.31
Net Current Asset Value
C$ 753.53KC$ 1.40MC$ 1.02MC$ 1.24MC$ 2.10M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.04 0.19
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.04 0.25
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.04 0.20
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.07 1.07 1.08 1.08 1.29
Debt Service Coverage Ratio
 0.00 0.00 0.00 -21.31 -10.19
Interest Coverage Ratio
 0.00 0.00 0.00 -23.03 -23.97
Debt to Market Cap
 0.00 0.00 0.00 0.03 <0.01
Interest Debt Per Share
 0.00 0.00 0.00 0.02 0.02
Net Debt to EBITDA
 0.31 3.03 3.32 0.70 0.65
Profitability Margins
Gross Profit Margin
-517.35%44.38%73.17%95.82%-924.59%
EBIT Margin
-1462.99%-1108.20%-344.95%-4275.35%-11612.33%
EBITDA Margin
-1462.99%-1108.20%-324.27%-4121.96%-10742.83%
Operating Profit Margin
-1462.99%-1108.20%-383.30%-1931.33%-11320.05%
Pretax Profit Margin
-1439.30%-1052.23%-344.95%-4134.66%-12084.50%
Net Profit Margin
-1439.30%-1052.23%-344.95%-4134.66%-12084.50%
Continuous Operations Profit Margin
-1439.30%-1052.23%-344.95%-4134.66%-12084.50%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
98.38%94.95%89.99%214.08%106.75%
Return on Assets (ROA)
-98.95%-30.02%-30.83%-127.36%-50.12%
Return on Equity (ROE)
-85.01%-32.04%-33.33%-137.08%-64.69%
Return on Capital Employed (ROCE)
-107.98%-33.74%-37.03%-63.66%-49.77%
Return on Invested Capital (ROIC)
-107.98%-33.74%-37.03%-56.51%-47.34%
Return on Tangible Assets
-140.10%-30.02%-30.83%-127.36%-50.30%
Earnings Yield
-53.30%-9.25%-53.15%-144.49%-7.26%
Efficiency Ratios
Receivables Turnover
 0.82 1.03 42.76 2.52 0.19
Payables Turnover
 51.04 0.54 0.56 0.09 1.81
Inventory Turnover
 3.37 1.39 0.00 0.21 15.82
Fixed Asset Turnover
 0.00 0.00 0.00 0.77 0.02
Asset Turnover
 0.07 0.03 0.09 0.03 <0.01
Working Capital Turnover Ratio
 0.09 0.04 0.09 0.02 <0.01
Cash Conversion Cycle
 547.33 -66.12 -641.77 -2.35K 1.76K
Days of Sales Outstanding
 446.22 353.27 8.54 144.85 1.94K
Days of Inventory Outstanding
 108.25 262.71 0.00 1.74K 23.07
Days of Payables Outstanding
 7.15 682.09 650.30 4.24K 201.43
Operating Cycle
 554.48 615.97 8.54 1.88K 1.97K
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 -0.07 -0.06 -0.12 -0.04
Free Cash Flow Per Share
 >-0.01 -0.07 -0.06 -0.12 -0.04
CapEx Per Share
 0.00 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 0.00 -120.26K -217.29
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 -120.26K -217.29
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 -9.57 -2.29
Operating Cash Flow to Sales Ratio
 -1.25 -8.04 -2.39 -11.16 -106.63
Free Cash Flow Yield
-7.06%-7.07%-36.77%-39.01%-6.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.21 -10.80 -1.88 -0.69 -13.77
Price-to-Sales (P/S) Ratio
 17.75 113.73 6.49 28.62 1.66K
Price-to-Book (P/B) Ratio
 1.99 3.46 0.63 0.95 8.91
Price-to-Free Cash Flow (P/FCF) Ratio
 -14.17 -14.14 -2.72 -2.56 -15.54
Price-to-Operating Cash Flow Ratio
 -21.55 -14.14 -2.72 -2.56 -15.61
Price-to-Earnings Growth (PEG) Ratio
 0.02 -0.49 0.02 >-0.01 -0.73
Price-to-Fair Value
 1.99 3.46 0.63 0.95 8.91
Enterprise Value Multiple
 -0.90 -7.23 1.32 0.01 -14.84
Enterprise Value
 1.07M 3.41M -420.80K -18.20K 25.58M
EV to EBITDA
 -0.90 -7.23 1.32 0.01 -14.84
EV to Sales
 13.23 80.14 -4.27 -0.42 1.59K
EV to Free Cash Flow
 -10.56 -9.96 1.79 0.04 -14.88
EV to Operating Cash Flow
 -10.56 -9.96 1.79 0.04 -14.95
Tangible Book Value Per Share
 0.06 0.30 0.24 0.32 0.07
Shareholders’ Equity Per Share
 0.09 0.30 0.24 0.32 0.07
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.05 0.00
Revenue Per Share
 <0.01 <0.01 0.02 0.01 <0.01
Net Income Per Share
 -0.10 -0.10 -0.08 -0.43 -0.05
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.98 0.95 1.00 0.97 1.04
Research & Development to Revenue
 0.02 0.07 0.00 0.01 3.85
SG&A to Revenue
 11.23 10.04 2.38 13.62 79.49
Stock-Based Compensation to Revenue
 1.03 2.29 0.18 1.94 5.35
Income Quality
 0.42 0.76 0.69 0.27 0.88
Currency in CAD